Clinical Trial: Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312734) titled 'Study to Enable New Diagnostics for Pulmonary Microbes in People With CF' on Oct. 23, 2025.

Brief Summary: Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is more difficult for people with CF to produce sputum even though they still have harmful bacteria in their lungs. The SEND-CF study is being done to see if there are other ways to detect harmful bacteria in the lungs.

Study Start Date: Feb. 01

Study Type: OBSERVATIONAL

Condition: Cystic Fibrosis (CF) New Diagnostics

Recruitment S...